Trial Profile
UCI 14-92 / HS#2015-1889: Phase IV Study of Daylight Photodynamic Therapy With Aminolevulinic Acid for Actinic Keratoses
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- 02 Nov 2017 New trial record